Crossmark

Resources utilisation and economic burden of percutaneous vertebroplasty or percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures in China: a retrospective claim database study

Crossref DOI link: https://doi.org/10.1186/s12891-020-03279-1

Published Online: 2020-04-17

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Dehong

Zhang, Yanlei

Ma, Xiao

Huo, Li

Li, Liran

Gao, Yue
Funding

Funding for this research was provided by:

Lilly Suzhou Pharmaceutical Co.Ltd Shanghai Branch
License Information

Text and Data Mining valid from 2020-04-17

Version of Record valid from 2020-04-17
More Information

Article History

Received: 5 September 2019

Accepted: 7 April 2020

First Online: 17 April 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: DHY declares that he has no competing interests; YLZ, XM, and LH declares that they are Eli Lilly and Company’s employees; LRL and YG report grants from Eli Lilly and Company, during the conduct of the study.

Document is current

Any future updates will be listed below